Export 87 results:
Author Title Type [ Year(Asc)]
Filters: Author is Chew, Emily Y  [Clear All Filters]
2017
K. Sleiman, Veerappan, M., Winter, K. P., McCall, M. N., Yiu, G., Farsiu, S., Chew, E. Y., Clemons, T., and Toth, C. A., “Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration.”, Ophthalmology, vol. 124, no. 12, pp. 1764-1777, 2017.
A. Domalpally, Clemons, T. E., Danis, R. P., Sadda, S. V. R., Cukras, C. A., Toth, C. A., Friberg, T. R., and Chew, E. Y., “Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research G”, Ophthalmology, vol. 124, no. 4, pp. 479-487, 2017.
2016
S. N. Al-Holou, Tucker, W. R., Agrón, E., Clemons, T. E., Sperduto, R. D., Ferris, F. L., and Chew, E. Y., “The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.”, Ophthalmology, vol. 123, no. 4, pp. 916-7, 2016.
H. E. Wiley, Thompson, D. J. S., Bailey, C., Chew, E. Y., Cukras, C. A., Jaffe, G. J., Lee, R. W. J., Loken, E. K., Meyerle, C. B., Wong, W., and Ferris, F. L., “A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.”, Ophthalmology, vol. 123, no. 4, pp. 841-9, 2016.
E. Y. Chew, Clemons, T. E., Harrington, M., Bressler, S. B., Elman, M. J., Kim, J. E., Garfinkel, R., Heier, J. S., Brucker, A., and Boyer, D., “EFFECTIVENESS OF DIFFERENT MONITORING MODALITIES IN THE DETECTION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The Home Study, Report Number 3.”, Retina, vol. 36, no. 8, pp. 1542-7, 2016.
S. Vitale, Clemons, T. E., Agrón, E., Ferris, F. L., Domalpally, A., Danis, R. P., and Chew, E. Y., “Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10.”, JAMA Ophthalmol, vol. 134, no. 9, pp. 1041-7, 2016.
M. Veerappan, El-Hage-Sleiman, A. - K. M., Tai, V., Chiu, S. J., Winter, K. P., Stinnett, S. S., Hwang, T. S., G Hubbard, B., Michelson, M., Gunther, R., Wong, W. T., Chew, E. Y., and Toth, C. A., “Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration.”, Ophthalmology, vol. 123, no. 12, pp. 2554-2570, 2016.
2015
T. S. Glaser, Doss, L. E., Shih, G., Nigam, D., Sperduto, R. D., Ferris, F. L., Agrón, E., Clemons, T. E., and Chew, E. Y., “The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37.”, Ophthalmology, vol. 122, no. 7, pp. 1471-9, 2015.
S. N. Al-Holou, Tucker, W. R., Agrón, E., Clemons, T. E., Cukras, C., Ferris, F. L., and Chew, E. Y., “The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.”, Ophthalmology, vol. 122, no. 12, pp. 2490-6, 2015.
M. Indaram, Agrón, E., Clemons, T. E., Sperduto, R. D., Wong, W. T., Ferris, F. L., and Chew, E. Y., “Changes in lens opacities on the age-related eye disease study grading scale predict progression to cataract surgery and vision loss: age-related eye disease study report no. 34.”, Ophthalmology, vol. 122, no. 5, pp. 888-96, 2015.
E. Y. Chew, Clemons, T. E., Peto, T., Sallo, F. B., Ingerman, A., Tao, W., Singerman, L., Schwartz, S. D., Peachey, N. S., and Bird, A. C., “Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial.”, Am J Ophthalmol, vol. 159, no. 4, pp. 659-666.e1, 2015.
E. Y. Chew, Clemons, T. E., Agrón, E., Launer, L. J., Grodstein, F., and Bernstein, P. S., “Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.”, JAMA, vol. 314, no. 8, pp. 791-801, 2015.
J. Flamendorf, Agrón, E., Wong, W. T., Thompson, D., Wiley, H. E., E Doss, L., Al-Holou, S., Ferris, F. L., Chew, E. Y., and Cukras, C., “Impairments in Dark Adaptation Are Associated with Age-Related Macular Degeneration Severity and Reticular Pseudodrusen.”, Ophthalmology, vol. 122, no. 10, pp. 2053-62, 2015.
2014
D. E. Bonds, Harrington, M., Worrall, B. B., Bertoni, A. G., Eaton, C. B., Hsia, J., Robinson, J., Clemons, T. E., Fine, L. J., and Chew, E. Y., “Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.”, JAMA Intern Med, vol. 174, no. 5, pp. 763-71, 2014.
E. Y. Chew and Clemons, T. E., “Experimental design issue for assessment of carotenoids lutein and zeaxanthin in age-related eye disease study 2 formulation for age-related macular degeneration--reply.”, JAMA Ophthalmol, vol. 132, no. 7, pp. 904-5, 2014.
P. A. Petrou, Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C. A., Ferris, F. L., Chew, E. Y., and Wong, W. T., “Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 56, no. 1, pp. 330-8, 2014.
E. Y. Chew, Klein, M. L., Clemons, T. E., Agrón, E., Ratnapriya, R., Edwards, A. O., Fritsche, L. G., Swaroop, A., and Abecasis, G. R., “No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.”, Ophthalmology, vol. 121, no. 11, pp. 2173-80, 2014.
E. Y. Chew, Clemons, T. E., Bressler, S. B., Elman, M. J., Danis, R. P., Domalpally, A., Heier, J. S., Kim, J. E., and Garfinkel, R., “Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study.”, Ophthalmology, vol. 121, no. 2, pp. 535-44, 2014.
E. Y. Chew, Clemons, T. E., Bressler, S. B., Elman, M. J., Danis, R. P., Domalpally, A., Heier, J. S., Kim, J. E., and Garfinkel, R. A., “Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design - HOME Study report number 1.”, Contemp Clin Trials, vol. 37, no. 2, pp. 294-300, 2014.
E. Y. Chew, Clemons, T. E., Sangiovanni, J. Paul, Danis, R. P., Ferris, F. L., Elman, M. J., Antoszyk, A. N., Ruby, A. J., Orth, D., Bressler, S. B., Fish, G. E., Hubbard, G. Baker, Klein, M. L., Chandra, S. R., Blodi, B. A., Domalpally, A., Friberg, T., Wong, W. T., Rosenfeld, P. J., Agrón, E., Toth, C. A., Bernstein, P. S., and Sperduto, R. D., “Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.”, JAMA Ophthalmol, vol. 132, no. 2, pp. 142-9, 2014.
E. Y. Chew, Clemons, T. E., Agrón, E., Sperduto, R. D., Sangiovanni, J. Paul, Davis, M. D., and Ferris, F. L., “Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.”, JAMA Ophthalmol, vol. 132, no. 3, pp. 272-7, 2014.
N. Huynh, Nicholson, B. P., Agrón, E., Clemons, T. E., Bressler, S. B., Rosenfeld, P. J., and Chew, E. Y., “Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.”, Ophthalmology, vol. 121, no. 6, pp. 1229-36, 2014.
2013
A. Domalpally, Danis, R. P., Chew, E. Y., Clemons, T. E., Reed, S., Sangiovanni, J. Paul, and Ferris, F. L., “Evaluation of optimized digital fundus reflex photographs for lens opacities in the age-related eye disease study 2: AREDS2 report 7.”, Invest Ophthalmol Vis Sci, vol. 54, no. 9, pp. 5989-94, 2013.
E. Y. Chew, Clemons, T. E., Agrón, E., Sperduto, R. D., Sangiovanni, J. Paul, Kurinij, N., and Davis, M. D., “Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.”, Ophthalmology, vol. 120, no. 8, pp. 1604-11.e4, 2013.
T. E. Clemons, Gillies, M. C., Chew, E. Y., Bird, A. C., Peto, T., Wang, J. Jin, Mitchell, P., Ramdas, W. D., and Vingerling, J. R., “Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3.”, Ophthalmic Epidemiol, vol. 20, no. 2, pp. 109-13, 2013.